Embold Therapeutics, Inc. funding
Embold Therapeutics, Inc., a biotechnology company based in Redwood City, CA (founded 2023), filed a Form D with the SEC on February 9, 2026 and reported $500K raised. It filed 2 new offerings in this period, totaling $630K.
Amount raised$500K
Offering size$500K
Filed with the SECFebruary 9, 2026
First saleJanuary 21, 2026
IndustryBiotechnology
SecuritiesOptions or warrants, Security to be acquired on exercise
LocationRedwood City, CA
Founded2023
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Feb 9
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| February 9, 2026 | $500K | $500K | Options or warrants, Security to be acquired on exercise |
| February 9, 2026 | $130K | $3M | Options or warrants, Security to be acquired on exercise |
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology